Total Number of Communication Reports: 0
Monthly communication reports in the last 6 months: 0
Subject matters | Details | Categories |
---|---|---|
Health, Research and Development, Science and Technology
|
Explore policies and programs with respect to rare diseases, including investigational therapeutics.
|
Policies or Program
|
Address:
2250, Alfred-Nobel Boulevard, Suite 301
Saint-Laurent, QC H4S 2C9
Canada
Telephone number:
514-332-3001
Fax number:
514-332-3107
Web address:
http://otsukacanada.com/home
Patricia Smith, Senior Director, Regulatory Affairs
Otsuka Canada Pharmaceutical Inc. is not a coalition.
The activities of Otsuka Canada Pharmaceutical Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Otsuka Canada Pharmaceutical Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Stephen Sampson | Public offices held
Firm: Global Public Affairs